糖尿病肾病精准医学实施前瞻：利益相关者共识会议结果

数据集获取（Figshare）

• 源站标题：DataSheet1_Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting.pdf
• DOI：10.3389/fphar.2021.662642.s001
• 发布日期：2021-05-05
• 文件数：1 个
• 文件总体积：280.76 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/DataSheet1_Perspectives_on_a_Way_Forward_to_Implementation_of_Precision_Medicine_in_Patients_With_Diabetic_Kidney_Disease_Results_of_a_Stakeholder_Consensus-Building_Meeting_pdf/14540520

命令行下载

curl -L -o "DataSheet1_Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Co.pdf" "https://ndownloader.figshare.com/files/27896394"

文件清单

• DataSheet1_Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Co.pdf（280.76 KB）

文件总体积 280.76 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Aim: This study aimed to identify from different stakeholders the benefits and obstacles of implementing precision medicine in diabetic kidney disease (DKD) and to build consensus about a way forward in order to treat, prevent, or even reverse this disease.
Methods: As part of an ongoing effort of moving implementation of precision medicine in DKD forward, a two-day consensus-building meeting was organized with different stakeholders involved in drug development and patient care in DKD, including patients, patient representatives, pharmaceutical industry, regulatory agencies representatives, health technology assessors, healthcare professionals, basic scientists, and clinical academic researchers. The meeting consisted of plenary presentations and discussions, and small group break-out sessions. Discussion topics were based on a symposium, focus groups and literature search. Benefits, obstacles and potential solutions toward implementing precision medicine were discussed. Results from the break-out sessions were presented in plenary and formed the basis of a broad consensus discussion to reach final conclusions. Throughout the meeting, participants answered several statement and open-ended questions on their mobile device, using a real-time online survey tool. Answers to the statement questions were analyzed descriptively. Results of the open-ended survey questions, the break-out sessions and the consensus discussion were analyzed qualitatively.
Results and conclusion: Seventy-one participants from 26 countries attended the consensus-building meeting in Amsterdam, April 2019. During the opening plenary on the first day, the participants agreed with the statement that precision medicine is the way forward in DKD (n = 57, median 90, IQR [75–100]). Lack of efficient tools for implementation in practice and generating robust data were identified as significant obstacles. The identified benefits, e.g., improvement of the benefit-risk ratio of treatment, offer substantive incentives to find solutions for the identified obstacles. Earlier and increased multi-stakeholder collaboration and specific training may provide solutions to alter clinical and regulatory guideline

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fphar.2021.662642.s001（source: https://frontiersin.figshare.com/articles/dataset/DataSheet1_Perspectives_on_a_Way_Forward_to_Implementation_of_Precision_Medicine_in_Patients_With_Diabetic_Kidney_Disease_Results_of_a_Stakeholder_Consensus-Building_Meeting_pdf/14540520）。